2022-2027
EXPAN
EXPAN
The aim of this study is to examine the feasibility and efficacy of a supervised, multicomponent exercise program in patients with localised pancreatic cancer undergoing preoperative therapy.
| TRIAL TITLE | A Multicomponent Exercise Medicine Programme in Patients with Pancreatic Cancer Undergoing Neoadjuvant Therapy (the EXPAN trial): A Two-armed Phase I Randomised Controlled Trial |
| CANCER TYPE | Pancreatic |
| TRIAL STATUS | Recruiting |
| PATIENT POPULATION | People with removable, potentially removable or locally advanced pancreatic cancer receiving treatment before surgery |
| ACKNOWLEDGEMENTS | This study has been funded by National Health and Medical Research Council through the Medical Research Future Fund – Clinical Trials Activity (Rare Cancer, Rare Diseases and Unmet Need) Initiative |
